AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glicsar-M Tablet

Prescription Icon
Prescription Required

Marketer

Sarthak Biotech Pvt Ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Glicsar-M Tablet

Diabex Duo tablets are classified as antidiabetic medications. This dual-drug formulation treats type 2 diabetes in adults by regulating blood glucose. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a holistic approach encompassing diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly influence diabetes control. Common adverse effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Always carry a readily available glucose source (e.g., sugary snacks or juice) to counter hypoglycemia. Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects are altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should inform their physician before starting treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (including blood cell counts and liver function) are necessary.

Uses of Glicsar-M Tablet

Adult-onset diabetes

Major Benefits of Glicsar-M Tablet:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glicsar-M should be administered with food.

Common Side effects of Glicsar-M Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glicsar-M Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glicsar-M Tablets. Ingest each tablet whole; do not crush, chew, or divide it. Consume Glicsar-M with a meal.

How Glicsar-M Tablet works:

Gliclazide and metformin are combined in Glicsar-M tablets to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while taking Glicsar-M tablets.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glicsar-M tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. Nevertheless, in exceptional, life-threatening circumstances, a physician might consider prescribing it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glicsar-M Tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Impaired driving is a possibility if your blood glucose level is either abnormally low or elevated. Refrain from driving should these conditions arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glicsar-M Tablets, potentially requiring dosage modification. Consult your physician for guidance. Glicsar-M Tablets are contraindicated for patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glicsar-M tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, Glicsar-M tablets should generally commence at a low dosage; however, their use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glicsar-M Tablet :

Should you forget a Glicsar-M Tablet dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glicsar-M Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glicsar-M Tablet

Glicsar-M tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glicsar-M is unsuitable for type 1 diabetes.
Glicsar-M Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glicsar-M Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Glicsar-M Tablet use can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is less likely in patients without kidney disease, who are not elderly, and who do not consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glicsar-M Tablet and seek immediate medical attention.
Prolonged Glicsar-M Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Glicsar-M Tablets are contraindicated in patients with hypersensitivity to any ingredient or excipient. Their use is also contraindicated in individuals with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Glicsar-M tablets and alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Glicsar-M tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Gliclazide boosts insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glicsar-M is not suitable for type 1 diabetes.
Glicsar-M Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glicsar-M Tablets can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Glicsar-M Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). While rare, this side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glicsar-M and seek immediate medical attention.
Prolonged Glicsar-M Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and gait problems), urinary issues, cognitive changes, and balance difficulties. To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Glicsar-M Tablets are contraindicated in patients with allergies to any ingredient or excipient. Their use is also contraindicated in individuals with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Glicsar-M tablets and alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Glicsar-M Tablet
29
MRP 35
17% off